Operating as the only biotech in the space since, they've landed big-money partnerships with Bayer and Merck, more venture cash and a couple more ...
News
- One of biotech's flashiest startups is finally getting some competition from a pioneer in a brand new ...
- Faheem Hasnain is going back to running a biotech startup. And he has his work cut out for him
Faheem Hasnain is going back to running a biotech startup. And he ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
- Laura Shawver is about to join a lineup of biotech CEOs enjoying overnight fortunes, courtesy of ...
Laura Shawver capped 2019 with an $88 million windfall from the sale of Synthorx to Sanofi. And she pivoted right back into the sweet spot in 2020.
- News briefing: FDA requests new trial for Reata's Friedreich's ataxia program; J&J's Tremfya picks ...
Reata $RETA shares took a nosedive Wednesday after the biotech ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
- After 5 quiet years, a former Scripps spinout raises $200M and announces plans to try again at an ...
The first time San Diego biotech Ambrx tried to go public in 2014, they failed and the company's board switched to a radically different strategy: They ...